Skip to content

CIK 0001845337

DAWN Day One Biopharmaceuticals, Inc.

Insider trading from SEC Form 4. Last filing Apr 27, 2026.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company

Signals

Open-market buys and sells at Day One Biopharmaceuticals, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
37WeakJeremy Bender
CHIEF EXECUTIVE OFFICER
sell
$179k
15,459 shares
-7%-
30WeakCharles N York II
COO and CFO
sell
$70k
6,065 shares
-2%-
30WeakMichael Vasconcelles
Head of Research and Dev.
sell
$32k
2,728 shares
-38%-
23WeakAdam Dubow
Gen Counsel & Secretary
sell
$74k
6,395 shares
-8%-
23WeakLauren Merendino
Chief Commercial Officer
sell
$67k
5,814 shares
-9%-
36WeakJeremy Bender
CHIEF EXECUTIVE OFFICER
sell
$142k
15,894 shares
-8%-
28WeakCharles N York II
COO and CFO
sell
$36k
4,062 shares
-1%-
21WeakAdam Dubow
Gen Counsel & Secretary
sell
$39k
4,319 shares
-6%-
21WeakLauren Merendino
Chief Commercial Officer
sell
$33k
3,726 shares
-7%-
35WeakJeremy Bender
CHIEF EXECUTIVE OFFICER
sell
$109k
16,058 shares
-9%-
20WeakLauren Merendino
Chief Commercial Officer
sell
$25k
3,766 shares
-8%-
20WeakAdam Dubow
Gen Counsel & Secretary
sell
$30k
4,365 shares
-7%-
27WeakCharles N York II
COO and CFO
sell
$28k
4,106 shares
-1%-
34WeakJeremy Bender
CHIEF EXECUTIVE OFFICER
sell
$87k
13,964 shares
-9%-
27WeakCharles N York II
COO, CFO AND SECRETARY
sell
$27k
4,282 shares
-2%-
20WeakAdam Dubow
GENERAL COUNSEL
sell
$28k
4,552 shares
-9%-
20WeakLauren Merendino
Chief Commercial Officer
sell
$25k
3,927 shares
-10%-
36WeakJeremy Bender
CHIEF EXECUTIVE OFFICER
sell
$144k
12,048 shares
-9%-
27WeakAdam Dubow
GENERAL COUNSEL
sell
$56k
4,646 shares
-10%-
29WeakCharles N York II
COO, CFO AND SECRETARY
sell
$52k
4,370 shares
-2%-
11WeakSamuel C. Blackman
HEAD OF R&D
sell
$399k
30,000 shares
-3%-
36WeakJeremy Bender
CHIEF EXECUTIVE OFFICER
sell
$139k
10,554 shares
-9%-
20WeakSamuel C. Blackman
HEAD OF R&D
sell
$29k
2,206 shares
-0%-
28WeakCharles N York II
COO, CFO AND SECRETARY
sell
$34k
2,602 shares
-1%-
21WeakAdam Dubow
GENERAL COUNSEL
sell
$42k
3,165 shares
-9%-
27WeakSamuel C. Blackman
HEAD OF R&D
sell
$456k
28,255 shares
-3%-
22WeakSamuel C. Blackman
HEAD OF R&D
sell
$180k
11,245 shares
-1%-
0WeakSamuel C. Blackman
HEAD OF R&D
sell
$8,010
500 shares
-0%-

Planned sales

Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales

FiledSellerSharesValueSale datePast 3 months
Nov 18, 2024 JEREMY BENDER
Officer, Director
10,554
0.01% of outstanding
$139kNov 18, 2024none
Nov 18, 2024 SAMUEL BLACKMAN
Officer
2,206
0.00% of outstanding
$29kNov 18, 2024$1.1M
Nov 12, 2024 SAMUEL BLACKMAN
Officer
50,000
0.05% of outstanding
$820kNov 11, 2024$941k
Oct 31, 2024 SAMUEL BLACKMAN
Officer
30,000
0.03% of outstanding
$434kOct 31, 2024$458k

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Apr 23, 2026AI Day1 LLC
owner
UTender of shares
Common Stock
-12,929,322$21.50$278M0Apr 27, 2026
Apr 23, 2026AI Day1 LLC
owner
DDisposition to issuer
Pre-Funded Warrant (right to buy)derivative
-827,586$21.50$18M0Apr 27, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Common Stock
+2,963--65,589Feb 18, 2026
Feb 15, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Common Stock
+4,750--181,915Feb 18, 2026
Feb 15, 2026Charles N York II
COO and CFO
MOption exercise
Common Stock
+2,250--296,965Feb 18, 2026
Feb 15, 2026Lauren Merendino
Chief Commercial Officer
MOption exercise
Common Stock
+3,162--53,971Feb 18, 2026
Feb 15, 2026Michael Vasconcelles
Head of Research and Dev.
MOption exercise
Common Stock
+7,125--7,125Feb 18, 2026
Feb 17, 2026Michael Vasconcelles
Head of Research and Dev.
SOpen-market sale
Common Stock
-2,728$11.60$32k4,397Feb 18, 2026
Feb 15, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Common Stock
+11,688--193,603Feb 18, 2026
Feb 15, 2026Charles N York II
COO and CFO
MOption exercise
Common Stock
+6,625--303,590Feb 18, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Common Stock
+1,750--67,339Feb 18, 2026
Feb 15, 2026Lauren Merendino
Chief Commercial Officer
MOption exercise
Common Stock
+3,688--57,659Feb 18, 2026
Feb 15, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Common Stock
+11,687--205,290Feb 18, 2026
Feb 15, 2026Lauren Merendino
Chief Commercial Officer
MOption exercise
Common Stock
+3,687--61,346Feb 18, 2026
Feb 15, 2026Charles N York II
COO and CFO
MOption exercise
Common Stock
+6,625--310,215Feb 18, 2026
Feb 15, 2026Michael Vasconcelles
Head of Research and Dev.
MOption exercise
Restricted Stock Unit (RSU)derivative
-7,125$0.00$0106,875Feb 18, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Common Stock
+3,688--71,027Feb 18, 2026
Feb 15, 2026Lauren Merendino
Chief Commercial Officer
MOption exercise
Common Stock
+4,625--65,971Feb 18, 2026
Feb 15, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Common Stock
+14,812--220,102Feb 18, 2026
Feb 15, 2026Charles N York II
COO and CFO
MOption exercise
Common Stock
+7,875--318,090Feb 18, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Common Stock
+3,687--74,714Feb 18, 2026
Feb 17, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
SOpen-market sale
Common Stock
-15,459$11.60$179k204,603Feb 18, 2026
Feb 17, 2026Charles N York II
COO and CFO
SOpen-market sale
Common Stock
-6,065$11.60$70k312,025Feb 18, 2026
Feb 17, 2026Lauren Merendino
Chief Commercial Officer
SOpen-market sale
Common Stock
-5,814$11.60$67k60,157Feb 18, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Common Stock
+4,375--79,089Feb 18, 2026
Feb 15, 2026Lauren Merendino
Chief Commercial Officer
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,162$0.00$018,978Feb 18, 2026
Feb 15, 2026Charles N York II
COO and CFO
MOption exercise
Restricted Stock Unit (RSU)derivative
-2,250$0.00$06,750Feb 18, 2026
Feb 17, 2026Adam Dubow
Gen Counsel & Secretary
SOpen-market sale
Common Stock
-6,395$11.60$74k72,694Feb 18, 2026
Feb 15, 2026Lauren Merendino
Chief Commercial Officer
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,688$0.00$025,816Feb 18, 2026
Feb 15, 2026Charles N York II
COO and CFO
MOption exercise
Restricted Stock Unit (RSU)derivative
-6,625$0.00$046,375Feb 18, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Restricted Stock Unit (RSU)derivative
-2,963$0.00$08,889Feb 18, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Restricted Stock Unit (RSU)derivative
-1,750$0.00$05,250Feb 18, 2026
Feb 15, 2026Lauren Merendino
Chief Commercial Officer
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,687$0.00$040,565Feb 18, 2026
Feb 15, 2026Charles N York II
COO and CFO
MOption exercise
Restricted Stock Unit (RSU)derivative
-6,625$0.00$072,875Feb 18, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,688$0.00$025,816Feb 18, 2026
Feb 15, 2026Charles N York II
COO and CFO
MOption exercise
Restricted Stock Unit (RSU)derivative
-7,875$0.00$0118,125Feb 18, 2026
Feb 15, 2026Lauren Merendino
Chief Commercial Officer
MOption exercise
Restricted Stock Units (RSU)derivative
-4,625$0.00$069,375Feb 18, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,687$0.00$040,565Feb 18, 2026
Feb 15, 2026Adam Dubow
Gen Counsel & Secretary
MOption exercise
Restricted Stock Unit (RSU)derivative
-4,375$0.00$065,625Feb 18, 2026
Feb 15, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Restricted Stock Unit (RSU)derivative
-4,750$0.00$014,250Feb 18, 2026
Feb 15, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Restricted Stock Unit (RSU)derivative
-11,688$0.00$081,816Feb 18, 2026
Feb 15, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Restricted Stock Unit (RSU)derivative
-11,687$0.00$0128,565Feb 18, 2026
Feb 15, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Restricted Stock Unit (RSU)derivative
-14,812$0.00$0222,188Feb 18, 2026
Jan 30, 2026Adam Dubow
Gen Counsel & Secretary
AGrant or award
Stock Option (right to buy Common Stock)derivative
+105,000$0.00$0105,000Jan 30, 2026
Jan 30, 2026Charles N York II
COO and CFO
AGrant or award
Stock Option (right to buy Common Stock)derivative
+188,000$0.00$0188,000Jan 30, 2026
Jan 30, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
AGrant or award
Stock Option (right to buy Common Stock)derivative
+355,000$0.00$0355,000Jan 30, 2026
Jan 30, 2026Michael Vasconcelles
Head of Research and Dev.
AGrant or award
Stock Option (right to buy Common Stock)derivative
+171,000$0.00$0171,000Jan 30, 2026
Jan 30, 2026Lauren Merendino
Chief Commercial Officer
AGrant or award
Stock Option (right to buy Common Stock)derivative
+110,000$0.00$0110,000Jan 30, 2026
Jan 30, 2026Jeremy Bender
CHIEF EXECUTIVE OFFICER
AGrant or award
Restricted Stock Unitsderivative
+237,000$0.00$0237,000Jan 30, 2026
Jan 30, 2026Charles N York II
COO and CFO
AGrant or award
Restricted Stock Unitsderivative
+126,000$0.00$0126,000Jan 30, 2026
Jan 30, 2026Michael Vasconcelles
Head of Research and Dev.
AGrant or award
Restricted Stock Unitsderivative
+114,000$0.00$0114,000Jan 30, 2026
Jan 30, 2026Adam Dubow
Gen Counsel & Secretary
AGrant or award
Restricted Stock Unitsderivative
+70,000$0.00$070,000Jan 30, 2026
Jan 30, 2026Lauren Merendino
Chief Commercial Officer
AGrant or award
Restricted Stock Unitsderivative
+74,000$0.00$074,000Jan 30, 2026
Nov 25, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
GGift
Common Stockindirect: By Bender Revocable Trust
-300,000$0.00$01,108,285Nov 26, 2025
Nov 25, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
GGift
Common Stockindirect: See footnote
+300,000$0.00$0300,000Nov 26, 2025
Nov 25, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
GGift
Common Stockindirect: By Bender Revocable Trust
-300,000$0.00$0808,285Nov 26, 2025
Nov 25, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
GGift
Common Stockindirect: See footnote
+300,000$0.00$0300,000Nov 26, 2025
Nov 25, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
GGift
Common Stockindirect: See footnote
-7,225$0.00$07,225Nov 26, 2025
Nov 25, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
GGift
Common Stockindirect: See footnote
-7,225$0.00$00Nov 26, 2025
Nov 15, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Common Stock
+3,570--164,935Nov 18, 2025
Nov 15, 2025Charles N York II
COO and CFO
MOption exercise
Common Stock
+1,375--283,277Nov 18, 2025
Nov 15, 2025Lauren Merendino
Chief Commercial Officer
MOption exercise
Common Stock
+3,162--47,161Nov 18, 2025
Nov 15, 2025Adam Dubow
Gen Counsel & Secretary
MOption exercise
Common Stock
+2,963--57,821Nov 18, 2025
Nov 15, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Common Stock
+4,750--169,685Nov 18, 2025
Nov 15, 2025Charles N York II
COO and CFO
MOption exercise
Common Stock
+2,250--285,527Nov 18, 2025
Nov 15, 2025Adam Dubow
Gen Counsel & Secretary
MOption exercise
Common Stock
+1,750--59,571Nov 18, 2025
Nov 15, 2025Lauren Merendino
Chief Commercial Officer
MOption exercise
Common Stock
+3,687--50,848Nov 18, 2025
Nov 15, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Common Stock
+11,687--181,372Nov 18, 2025
Nov 15, 2025Charles N York II
COO and CFO
MOption exercise
Common Stock
+6,625--292,152Nov 18, 2025
Nov 15, 2025Adam Dubow
Gen Counsel & Secretary
MOption exercise
Common Stock
+3,687--63,258Nov 18, 2025
Nov 15, 2025Lauren Merendino
Chief Commercial Officer
MOption exercise
Common Stock
+3,687--54,535Nov 18, 2025
Nov 15, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Common Stock
+11,687--193,059Nov 18, 2025
Nov 15, 2025Charles N York II
COO and CFO
MOption exercise
Common Stock
+6,625--298,777Nov 18, 2025
Nov 15, 2025Adam Dubow
Gen Counsel & Secretary
MOption exercise
Common Stock
+3,687--66,945Nov 18, 2025
Nov 17, 2025Lauren Merendino
Chief Commercial Officer
SOpen-market sale
Common Stock
-3,726$8.91$33k50,809Nov 18, 2025
Nov 15, 2025Lauren Merendino
Chief Commercial Officer
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,162$0.00$022,140Nov 18, 2025
Nov 17, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
SOpen-market sale
Common Stock
-15,894$8.91$142k177,165Nov 18, 2025
Nov 17, 2025Charles N York II
COO and CFO
SOpen-market sale
Common Stock
-4,062$8.91$36k294,715Nov 18, 2025
Nov 17, 2025Adam Dubow
Gen Counsel & Secretary
SOpen-market sale
Common Stock
-4,319$8.91$39k62,626Nov 18, 2025
Nov 15, 2025Charles N York II
COO and CFO
MOption exercise
Restricted Stock Unit (RSU)derivative
-1,375$0.00$00Nov 18, 2025
Nov 15, 2025Adam Dubow
Gen Counsel & Secretary
MOption exercise
Restricted Stock Unit (RSU)derivative
-2,963$0.00$011,852Nov 18, 2025
Nov 15, 2025Lauren Merendino
Chief Commercial Officer
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,687$0.00$029,504Nov 18, 2025
Nov 15, 2025Charles N York II
COO and CFO
MOption exercise
Restricted Stock Unit (RSU)derivative
-2,250$0.00$09,000Nov 18, 2025
Nov 15, 2025Adam Dubow
Gen Counsel & Secretary
MOption exercise
Restricted Stock Unit (RSU)derivative
-1,750$0.00$07,000Nov 18, 2025
Nov 15, 2025Lauren Merendino
Chief Commercial Officer
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,687$0.00$044,252Nov 18, 2025
Nov 15, 2025Charles N York II
COO and CFO
MOption exercise
Restricted Stock Unit (RSU)derivative
-6,625$0.00$053,000Nov 18, 2025
Nov 15, 2025Adam Dubow
Gen Counsel & Secretary
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,687$0.00$029,504Nov 18, 2025
Nov 15, 2025Charles N York II
COO and CFO
MOption exercise
Restricted Stock Unit (RSU)derivative
-6,625$0.00$079,500Nov 18, 2025
Nov 15, 2025Adam Dubow
Gen Counsel & Secretary
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,687$0.00$044,252Nov 18, 2025
Nov 15, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Restricted Stock Unit (RSU)derivative
-3,570$0.00$00Nov 18, 2025
Nov 15, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Restricted Stock Unit (RSU)derivative
-4,750$0.00$019,000Nov 18, 2025
Nov 15, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Restricted Stock Unit (RSU)derivative
-11,687$0.00$093,504Nov 18, 2025
Nov 15, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
MOption exercise
Restricted Stock Unit (RSU)derivative
-11,687$0.00$0140,252Nov 18, 2025
Nov 6, 2025Jeremy Bender
CHIEF EXECUTIVE OFFICER
DDisposition to issuer
Stock Option (right to buy Common Stock)derivative
-1,463,134$0.00$00Nov 7, 2025
Nov 6, 2025Charles N York II
COO and CFO
DDisposition to issuer
Stock Option (right to buy Common Stock)derivative
-497,667$0.00$00Nov 7, 2025
Nov 6, 2025Garry A Nicholson
director
DDisposition to issuer
Stock Option (right to buy Common Stock)derivative
-33,900$0.00$00Nov 7, 2025
Nov 6, 2025Natalie C. Holles
director
DDisposition to issuer
Stock Option (right to buy Common Stock)derivative
-40,000$0.00$00Nov 7, 2025
Nov 6, 2025Saira Ramasastry
director
DDisposition to issuer
Stock Option (right to buy Common Stock)derivative
-40,000$0.00$00Nov 7, 2025
Nov 6, 2025J. Scott Garland
director
DDisposition to issuer
Stock Option (right to buy Common Stock)derivative
-48,072$0.00$00Nov 7, 2025
Nov 6, 2025Habib J Dable
director
DDisposition to issuer
Stock Option (right to buy Common Stock)derivative
-66,660$0.00$00Nov 7, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

DAWN insider trading: Day One Biopharmaceuticals, Inc. | InsiderTell